Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Japan Pharmaceutical Industry Co., Ltd. (Nihon Seiyaku Kogyo) is a Japanese pharmaceutical and nutraceutical company specialized in over-the-counter (OTC) drugs, health foods, and traditional herbal medicines (Kampo). Founded in 1947 and headquartered in Komaki, Aichi Prefecture, the company is a member of the NHC Group and operates under a mission to support healthy lifestyles through products derived from natural materials. Its core pharmaceutical portfolio includes circulatory treatments such as Seishingen and nutritional tonics like Okisopin Z, which incorporate rare animal and plant extracts such as bezoar and ginseng. The company maintains GMP-certified manufacturing capabilities in Aichi and has expanded into specialized health ingredient production at its Kitami plant in Hokkaido, focusing on fermented products like black garlic.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Japan Pharmaceutical Industry.